Stroke Research and Treatment / 2010 / Article / Tab 2

Clinical Study

Clinical Analysis on Alteration of Thyroid Hormones in the Serum of Patients with Acute Ischemic Stroke

Table 2

Stroke outcome measured by National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS).

Low T3 groupNormal T3 group
(T3 ≤ 75 ng/dL)(T3 > 75 ng/dL)

The 1st day
Median value of NIHSS11 (5~19)6 (2~14)*

The 1st clinic follow-up
Median value of NIHSS9 (2~17)4 (0~9)*
Patients with any improvement (ΔNIHSS ≥ 2)8 (27.6%)12 (66.7%)*
Median value of mRS3 (1~5)1 (0~3)*
Patients with favorable outcome (mRS ≤ 1)9 (31.0%)10 (55.6%)*

Numbers in parentheses for nominal data indicate percentages and for continuous data indicate range of actual scores. *P<.05 is compared to low T3 group. The 1st day: on admission; The 1st clinic follow-up: outpatient follow-up usually occurred 2–4 weeks after discharge; ΔNIHSS 2: improvement when scores decreased ≥2 compared to baseline.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.